Swissmedic informs about Control Campaign against illegal Trading in Medicinal Products

Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The flourishing illegal online trade in medicinal products poses a serious threat: it not only endangers the health of consumers but also undermines the safety and regulation of the pharmaceutical supply chain. To address this issue, Swissmedic, the Federal Office for Customs and Border Security (FOCBS) and Swiss Sport Integrity (SSI) participated in an international campaign, coordinated with Europol, to inspect over 1,000 suspicious postal shipments.
According to a Swissmedic press release dated 18 December 2024, approximately one-quarter of the inspected shipments contained illegal medicinal products or doping agents. A total of 246 packages were seized, containing products such as erectile stimulants and narcotics. Over 90% of the confiscated items originated from India, often shipped through concealed routes.
These findings highlight the critical importance of international cooperation in combating the illegal trade in medicinal products. At the same time, they draw attention to the significant health risks and the support of criminal networks associated with the purchase of such products.
The insights gained from the inspections have been shared with Europol to further intensify international efforts against the illegal trade and to strengthen the safety of the pharmaceutical supply chain.
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates